These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38542291)

  • 1. Unveiling Prognostic RNA Biomarkers through a Multi-Cohort Study in Colorectal Cancer.
    Kim Z; Lee J; Yoon YE; Yun JW
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
    Yu J; Yang K; Zheng J; Sun X; Zhao W
    Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Prognostic Colorectal Cancer Model Including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 Based on Bioinformatics Analysis.
    Shi ZL; Zhou GQ; Guo J; Yang XL; Yu C; Shen CL; Zhu XG
    Cancer Biother Radiopharm; 2022 Dec; 37(10):893-906. PubMed ID: 33481661
    [No Abstract]   [Full Text] [Related]  

  • 5. Long noncoding RNA ZEB1-AS1 expression predicts progression and poor prognosis of colorectal cancer.
    Fu J; Cui Y
    Int J Biol Markers; 2017 Oct; 32(4):e428-e433. PubMed ID: 28967064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer.
    Xu K; He J; Zhang J; Liu T; Yang F; Ren T
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
    Liang Z; Li X
    Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation.
    Hosseini ST; Nemati F
    Sci Rep; 2023 Oct; 13(1):17086. PubMed ID: 37816854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
    Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
    Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
    Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
    BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis.
    Liang Y; Sun HX; Ma B; Meng QK
    Dis Markers; 2022; 2022():4556585. PubMed ID: 35711569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Biomarkers Associated with the Prognoses of Colorectal Cancer Patients.
    Fang Y; Zhan X
    Digestion; 2023; 104(2):148-162. PubMed ID: 36577392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of long non-coding RNA ZEB1-AS1 promotes colorectal cancer cell proliferation partially by suppressing p15 expression.
    Gong H; Wen H; Zhu X; Lian Y; Yang X; Qian Z; Zhu J
    Tumour Biol; 2017 Jun; 39(6):1010428317705336. PubMed ID: 28618933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
    Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
    BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response.
    Li C; Zhang K; Gong Y; Wu Q; Zhang Y; Dong Y; Li D; Wang Z
    Front Pharmacol; 2023; 14():1200054. PubMed ID: 37377924
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
    Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
    BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.